Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05708092 · ClinicalTrials.gov registry record · NA
NRF for Improved Re-Entry Outcomes for Offenders With Brain Injury (Brain Injury RE)
A NA study of Brain Injury, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- NA
- Development phase
- 1,022
- Enrollment target
- 2
- Study locations
NCT05708092: Active NA study of Brain Injury, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05708092 is a NA study of Brain Injury that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,022 participants, below the 5,088-participant average among 10 other Brain Injury trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05708092, a NA study of Brain Injury, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,022 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the effectiveness of NeuroResource Facilitation, a novel/innovative intervention, in reducing recidivism in offenders with brain injury (BI).
Primary Outcome
According to the PADOC, rearrest is measured as the first instance of arrest after inmates are released from state prison and reincarceration is measured as the first instance of returning to state prison after an offender is released from state prison. Overall recidivism is measured as the first instance of any type of rearrest or reincarceration after inmates are released from state prison.
Conditions Studied
Interventions
- BEHAVIORAL NeuroResource Facilitation (NRF)
Study Locations (2)
New York
- Icahn School of Medicine at Mount Sinai - New York
Pennsylvania
- Brain Injury Association of Pennsylvania - Carlisle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,022 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT05708092 still lists
NCT05708092 is an interventional study that assigns participants to a tested intervention. Its 1,022 participants enrollment target places it among the larger protocols in the corpus, below the 5,088-participant average among 10 other Brain Injury trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which NeuroResource Facilitation (NRF) is the first listed.
NCT05708092 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05708092 about?
NCT05708092 is a clinical study titled "NRF for Improved Re-Entry Outcomes for Offenders With Brain Injury (Brain Injury RE)". The purpose of this study is to evaluate the effectiveness of NeuroResource Facilitation, a novel/innovative intervention, in reducing recidivism in offenders with brain injury (BI).
What is the current status of trial NCT05708092?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,022 participants. The study started on 2022-03-22. Estimated completion is 2026-12-31.
What conditions does trial NCT05708092 study?
This clinical trial studies the following conditions: Brain Injury.
What interventions are being tested in trial NCT05708092?
The interventions under investigation include: NeuroResource Facilitation (NRF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05708092?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05708092 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05708092's enrollment target sits among peer trials
1,022 2nd of 10 the highest of 10 other Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innovative Multimodal and Attention Training to Improve Emotion Communication in Veterans With TBI and PTSD
RECRUITING · NA
-
Multifaceted Intervention to Restore Resilience and Overcome Risk
RECRUITING · NA
-
Q Therapeutic System for Chronic Stroke Recovery
RECRUITING · NA
-
Paired Vagus Nerve Stimulation in Mobilization of Patients With Prolonged Disorders of Consciousness
RECRUITING · NA
-
Comparing Telehealth to In-person a Combined Metacognitive Training in Veterans With mTBI/PTSD
RECRUITING · NA
-
University of Central Florida CereBank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07216703 · 1,023 participants · Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- NCT05225428 · 1,020 participants · NA
Video Education With Result Dependent dIsclosure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI